Renee D Gala - Net Worth and Insider Trading

Renee D Gala Net Worth

The estimated net worth of Renee D Gala is at least $7 Million dollars as of 2024-11-10. Renee D Gala is the EVP & CFO of Jazz Pharmaceuticals PLC and owns about 35,978 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Renee D Gala is the SVP, CFO of Theravance Biopharma Inc and owns about 171,049 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Renee D Gala is also the Director of Corcept Therapeutics Inc and owns about 10,000 shares of Corcept Therapeutics Inc (CORT) stock worth over $596,000. Details can be seen in Renee D Gala's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renee D Gala has not made any transactions after 2023-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Renee D Gala

To

Renee D Gala Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renee D Gala owns 4 companies in total, including Gossamer Bio Inc (GOSS) , Jazz Pharmaceuticals PLC (JAZZ) , and Theravance Biopharma Inc (TBPH) among others .

Click here to see the complete history of Renee D Gala’s form 4 insider trades.

Insider Ownership Summary of Renee D Gala

Ticker Comapny Transaction Date Type of Owner
GOSS Gossamer Bio Inc 2019-02-07 director
JAZZ Jazz Pharmaceuticals PLC 2023-05-18 EVP & CFO
TBPH Theravance Biopharma Inc 2018-08-15 VP-Finance
LIMIT LIMIT 2018-03-07 director

Renee D Gala Latest Holdings Summary

Renee D Gala currently owns a total of 3 stocks. Among these stocks, Renee D Gala owns 35,978 shares of Jazz Pharmaceuticals PLC (JAZZ) as of May 18, 2023, with a value of $4 Million and a weighting of 67.67%. Renee D Gala owns 171,049 shares of Theravance Biopharma Inc (TBPH) as of August 15, 2018, with a value of $2 Million and a weighting of 23.27%. Renee D Gala also owns 10,000 shares of Corcept Therapeutics Inc (CORT) as of March 7, 2018, with a value of $596,000 and a weighting of 9.07%.

Latest Holdings of Renee D Gala

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2023-05-18 35,978 123.62 4,447,600
TBPH Theravance Biopharma Inc 2018-08-15 171,049 8.94 1,529,178
CORT Corcept Therapeutics Inc 2018-03-07 10,000 59.60 596,000

Holding Weightings of Renee D Gala


Renee D Gala Form 4 Trading Tracker

According to the SEC Form 4 filings, Renee D Gala has made a total of 2 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 6,000 shares on May 18, 2023, which brought Renee D Gala around $790,500.

According to the SEC Form 4 filings, Renee D Gala has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the sale of 43,743 shares on August 15, 2018, which brought Renee D Gala around $1 Million.

According to the SEC Form 4 filings, Renee D Gala has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the acquisition of 10,000 shares on March 7, 2018, which cost Renee D Gala around $155,100.

Insider Trading History of Renee D Gala

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renee D Gala Trading Performance

GuruFocus tracks the stock performance after each of Renee D Gala's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renee D Gala is 27.75%. GuruFocus also compares Renee D Gala's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renee D Gala within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Renee D Gala's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Renee D Gala

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.28 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.19 LIMIT LIMIT LIMIT LIMIT LIMIT

Renee D Gala Ownership Network

Ownership Network List of Renee D Gala

No Data

Ownership Network Relation of Renee D Gala

Insider Network Chart

Renee D Gala Owned Company Details

What does Gossamer Bio Inc do?

Who are the key executives at Gossamer Bio Inc?

Renee D Gala is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and Chief Financial Officer Bryan Giraudo .

Gossamer Bio Inc (GOSS) Insider Trades Summary

Over the past 18 months, Renee D Gala made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net sale of 7,740 shares made by Richard Aranda , and a net purchase of 348,828 shares made by Faheem Hasnain .

In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,790 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 681,210 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Gossamer Bio Inc Insider Transactions

No Available Data

Renee D Gala Mailing Address

Above is the net worth, insider trading, and ownership report for Renee D Gala. You might contact Renee D Gala via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.